Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma

NCT00003715 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

425

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated: recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: BCG vaccine
BIOLOGICAL: autologous tumor cell vaccine
BIOLOGICAL: recombinant interferon alfa
DRUG: chemotherapy
DRUG: cyclophosphamide

Sponsor

AVAX Technologies